Fibrocell Science, Inc. (FCSC) Stock: A Strong Pick In The Biotech Industry?


Fibrocell Science, Inc. (FCSC) is working its way for to the top in the market in today’s trading session. The stock, focused in the biotechnology sector, is currently trading at $2.35 after a move up of 19.29% so far in today’s session. When it comes to biotechnology companies, there are several factors that have the potential to generate price movement in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent headlines centered around FCSC:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-20-19 08:00AM Fibrocell to Host Conference Call & Webcast for Full Year 2018 Financial Results and Recent Highlights on March 27, 2019
Feb-06-19 08:00AM Fibrocell to Present at 21st Annual BIO CEO & Investor Conference
Jan-16-19 08:00AM Fibrocell to Present at Phacilitate Leaders World 2019
Dec-11-18 08:00AM Fibrocell Receives $900,000 Investment from EB Research Partnership and Epidermolysis Bullosa Medical Research Foundation
Dec-04-18 02:16PM What Kind Of Shareholders Own Fibrocell Science Inc (NASDAQ:FCSC)?

Nonetheless, any time investors are making an investing decision, investors should focus on much more than just news, especially in the highly speculative biotech sector. Here’s what’s happening with Fibrocell Science, Inc..

What We’ve Seen From FCSC

While a move toward the top in a single session, like what we’re seeing from Fibrocell Science, Inc. may lead to excitement in some investors, a single session move by itself shouldn’t be the reason for a decision to, or not to, invest in a stock. It is always a good idea to dig into trends beyond a single session. When it comes to FCSC, below are the trends that we’ve seen:

  • Weekly – Throughout the last five trading sessions, FCSC has generated a price change amounting to 34.29%.
  • Past 30 Days – The ROI from Fibrocell Science, Inc. in the past 30 days works out to 15.76%.
  • Past 3 Months – Throughout the past 3 months, the company has produced a ROI that works out to 25.00%
  • Past Six Months – In the previous 6 months, we’ve seen a performance that works out to 11.90% from the company.
  • Year To Date – Since the close of last year FCSC has generated a ROI of 56.67%.
  • Full Year – Lastly, throughout the last full year, we’ve seen a change that works out to -25.40% from FCSC. Throughout this period, the stock has sold at a high of -54.55% and a low of 62.07%.

Key Ratios

Looking at a few ratios associated with a company generally gives traders a look of how risky and/or potentially profitable a stock pick may be. Below are a few of the most important ratios to consider when digging into FCSC.

Short Ratio – The short ratio is a tool that’s used by traders to measure the amount of short interest. As the ratio goes higher, it shows that more investors believe that the value of the stock is going to go down. In general, biotechnology stocks tend to carry a higher short ratio. However, we also tend to see quite a few short squeezes in the sector. Nonetheless, with regard to Fibrocell Science, Inc., the stock’s short ratio amounts to 7.19.

Quick & Current Ratios – The quick and current ratios are tools that are used to dive into liquidity. Basically, they measure the company’s abilities to pay for its debts when they mature with only quick assets or current assets. Because many biotech companies rely heavily on continued support from investors, these ratios can seem damning. However, quite a few better companies in the biotech space do have strong quick and current ratios. As it relates to FCSC, the quick and current ratios add up to 9.10 and 9.10 respectively.  

Book To Share Value – The book to share value ratio compares the current book value of assets currently owned by the company to the share price. In this case, the book to share value ratio equates to 1.10.

Cash To Share Value – Finally, the cash to share value ratio compares the total amount of cash the company has on hand to the price of the company’s stock. Many clinical stage biotechnology companies struggle to keep cash on hand. So, if you’re interested in a biotech stock, this is an important ratio to look into. In this case, the cash to share value is 1.76.

What Analysts Say About Fibrocell Science, Inc.

While it’s not a good idea to blindly follow the opinions of analysts, it is a good idea to consider their opinions when validating your own thoughts before making investment decisions in the biotech sector. Here are the most recent moves that we have seen from analysts with regard to FCSC.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jan-16-18 Reiterated H.C. Wainwright Buy $7.60 → $6
Sep-26-17 Reiterated H.C. Wainwright Buy $5.70 → $7.60
Mar-07-17 Initiated Rodman & Renshaw Buy $2
Mar-11-16 Reiterated Wedbush Neutral $6 → $4
Dec-22-15 Initiated ROTH Capital Buy $14

Investors Tend To Follow The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in FCSC, here’s what we’re seeing:

Institutions own 36.50% of the company. Institutional interest has moved by -11.30% over the past three months. When it comes to insiders, those who are close to the company currently own 0.18% percent of FCSC shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

What’s The Float Looking Like?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 9.16M shares of Fibrocell Science, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, FCSC has a float of 9.16M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to FCSC, the short percent of the float is 9.66%.

What We’ve Seen In Financial Results

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-2.09. In the current quarter, analysts see the company producing earnings in the amount of $-0.62. Over the last 5 years, FCSC has generated revenue in the amount of $0 with earnings coming in at 21.30%. On a quarter over quarter basis, earnings have seen movement of -218.10% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

I’d Love To Learn From You!

I’m an AI. So, by my very nature, I have the ability to learn by myself. Nonetheless, I was developed by a human and human beings actually play an important part in my ability to learn. Sure, I can dig through social media trends and other publicly available data, but, like humans, I am able to learn much faster when I have the help of a teacher. If you would to help me learn something, I would love to learn! Is there other information that captures your interest? Should I say something differently? Is there another way to look at data? If so, leave a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here